MTNB (STOCKS)
Matinas BioPharma Holdings, Inc.
$0.510000
+0.010000 (+2.00%)
Prev close: $0.500000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jerome D. Jabbour
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.22M
- Employees
- 34
- P/E (TTM)
- -0.25
- P/B (TTM)
- 0.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-0.82 | $-0.91 | +0.0878 | +9.67% |
|
Sep 2024 (Q3)
|
$-0.85 | $-1.08 | +0.2261 | +21.01% |
|
Jun 2024 (Q2)
|
$-1.00 | $-1.28 | +0.2750 | +21.57% |
|
Mar 2024 (Q1)
|
$-1.50 | $-1.53 | +0.0300 | +1.96% |
Financial Statements
| Revenues | $0.00 |
| Costs And Expenses | $6.96M |
| Depreciation and Amortization | $32.00K |
| Research and Development | $85.00K |
| Operating Income/Loss | -$6.96M |
| Income/Loss From Continuing Operations After Tax | -$10.35M |
| Income/Loss From Continuing Operations Before Tax | -$10.35M |
| Income Tax Expense/Benefit | $7.00K |
| Income Tax Expense/Benefit, Current | $7.00K |
| Net Income/Loss | -$10.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $618.00K |
| Preferred Stock Dividends And Other Adjustments | $618.00K |
| Basic Earnings Per Share | -$2.00 |
| Diluted Earnings Per Share | -$2.00 |
| Basic Average Shares | 5,474,129 |
| Diluted Average Shares | 5,474,129 |
| Assets | $7.21M |
| Current Assets | $4.08M |
| Noncurrent Assets | $3.13M |
| Fixed Assets | $138.00K |
| Intangible Assets | $2.26M |
| Other Non-current Assets | $735.00K |
| Liabilities | $2.38M |
| Current Liabilities | $1.46M |
| Accounts Payable | $315.00K |
| Other Current Liabilities | $1.15M |
| Noncurrent Liabilities | $915.00K |
| Equity | $4.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.83M |
| Liabilities And Equity | $7.21M |
| Net Cash Flow From Operating Activities | -$7.01M |
| Net Cash Flow From Operating Activities, Continuing | -$7.01M |
| Net Cash Flow From Investing Activities | $335.00K |
| Net Cash Flow From Investing Activities, Continuing | $335.00K |
| Net Cash Flow From Financing Activities | $3.39M |
| Net Cash Flow From Financing Activities, Continuing | $3.39M |
| Net Cash Flow | -$3.29M |
| Net Cash Flow, Continuing | -$3.29M |
| Comprehensive Income/Loss | -$10.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.35M |
| Other Comprehensive Income/Loss | -$10.35M |